Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Regulus Therapeutics Inc. (RGLS)
Sector: Healthcare; Industry: Biotechnology

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States and Europe. Its two lead product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS4326, an anti-miR targeting miR-17, which is in Phase I clinical trial for the treatment of autosomal dominant polycystic kidney disease.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-05-17 Aker Christopher Ray Sr. VP & General Counsel Sell 860 $0.89 $765 No
2021-02-16 Hagan Joseph P President and CEO Sell 4,144 $1.72 $7,128 No
2021-02-16 Aker Christopher Ray Sr. VP & General Counsel Sell 828 $1.72 $1,424 No
2021-02-16 Hagan Joseph P President and CEO Sell 4,144 $1.72 $7,128 No
2020-12-04 Walker Paul Edward 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 Sonsini Peter W. 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 SANDELL SCOTT D 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 MAKOWER JOSHUA 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 Makhzoumi Mohamad 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 Florence Anthony A. Jr. 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 Chang Carmen 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 Behbahani Ali 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 BASKETT FOREST 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 Growth Equity Opportunities V, LLC 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-11-16 Aker Christopher Ray Sr. VP & General Counsel Sell 876 $0.52 $456 No
2020-11-16 Hagan Joseph P President and CEO Sell 6,094 $0.52 $3,176 No
2020-08-14 Hagan Joseph P President and CEO Sell 4,245 $0.60 $2,568 No
2020-08-14 Aker Christopher Ray Sr. VP & General Counsel Sell 872 $0.60 $528 No
2020-05-15 Hagan Joseph P President and CEO Sell 4,426 $0.63 $2,774 No
2020-05-15 Aker Christopher Ray Sr. VP & General Counsel Sell 909 $0.63 $570 No
2020-02-18 Hagan Joseph P President and CEO Sell 4,324 $0.83 $3,591 No
2020-02-18 Aker Christopher Ray Sr. VP & General Counsel Sell 888 $0.83 $737 No
2020-01-02 Hagan Joseph P President and CEO Sell 8,345 $0.97 $8,067 No
2020-01-02 Aker Christopher Ray Sr. VP & General Counsel Sell 2,239 $0.97 $2,164 No
2019-11-14 Aker Christopher Ray Sr. VP & General Counsel Sell 833 $0.64 $533 No
2019-11-14 Hagan Joseph P President and CEO Sell 5,838 $0.64 $3,736 No
2019-10-01 Aker Christopher Ray Sr. VP & General Counsel Sell 2,346 $0.68 $1,602 No
2019-10-01 Hagan Joseph P President and CEO Sell 8,743 $0.68 $5,969 No
2019-08-15 Hagan Joseph P President and CEO Sell 4,375 $0.55 $2,409 No
2019-08-15 Aker Christopher Ray Sr. VP & General Counsel Sell 899 $0.55 $495 No

Insider Smart

Enphase Energy, Inc (ENPH) - ENPH was $10+ in 15Q1 then dropped to $2 and eventually went under $1. From 15Q4 to 17Q4 it built a 2-year-long base then BOOM! Stock went as high as $70 and likely will make a new high. Catch one or two moves like this you can retire early. One hint before the big move was that CEO and CFO were constantly accumulating, this kind of information is priceless.

Insider Smart

Carvana Co (CVNA) - One of the best timed insider buying in the crash is from GARCIA ERNEST C. II 10%-owner of CVNA. Bought at 45 and now with a 100%+ profit.